Over the last four months all Ambu’s attention has been focused on the integration of the American anesthesia company King Systems, which Ambu acquired for about USD 125m plus possible milestone payments and two so-called earn-out agreements. The last few months have been spent on three things in particular.
“One was securing our combined sales organisation. It has now been integrated into the organisation. Meanwhile, we have ensured that our IT systems are up and running, which usually takes years. Thirdly, our U.S. production is now a fully integrated part of our four other factories around the world. So far we haven’t focused on Europe at all. We have purposely said that anything pertaining to integration will take place in the U.S.,” CEO Lars Marcher tells Medwatch in an interview.